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The  latex  of  Calotropis  procera  is a  rich  source  of proteolytic  activity.  This latex  is  known  to  contain
two  distinct  cysteine  peptidases:  procerain  and  procerain  B.  In this  study, new  cysteine  peptidases  were
puriﬁed  from  C. procera  latex.  The enzymes  were  puriﬁed  by  two sequential  ion-exchange  chromatog-
raphy  steps  (CM-Sepharose  plus  Resource  S®) at pH 5.0  and  6.0.  The  puriﬁed  enzymes  had  molecular
mass  spectra  corresponding  to CpCP-1  = 26,213,  CpCP-2  =  26,133  and CpCP-3  = 25,086  Da.  These  enzymes
exhibited  discrete  differences  in  terms  of  enzymatic  activity  at a  broad  range of  pH  and  temperatureaticifers
eptidases
rocerain
hrombin-like
conditions  and  contained  identical  N-terminal  amino  acid  sequences.  In these  respects,  these  three  new
proteins are  distinct  from  those  previously  studied  (procerain  and  procerain  B). Circular  dichroism  analy-
sis revealed  that  the  new  peptidases  contain  extensive  secondary  structures,  (15–20%)  and  (26–30%),
that  were  stabilized  by disulﬁde  bonds.  The  puriﬁed  enzymes  exhibited  plasma-clotting  activity  medi-
ated  by a  thrombin-like  mechanism.  The  set  of  results  suggest  the  three  isolated  polypeptides  correspond
ionallto  different  post-translat
. Introduction
Proteolytic enzymes are a feedstock for many types of industrial
rocesses. In addition to their catalytic speciﬁcity, a high stability
f activity in a broad range of pH levels and temperatures is greatly
esired. A lack of these characteristics frequently limits the useful-
ess of an enzyme for industrial processes, and the search for new
roteolytic sources continues.
Latex ﬂuids have been recognized as a source of proteolytic
nzymes. Papain from the latex of Carica papaya is one of the most
tudied peptidases and is commercially available [1]. Proteolytic
nzymes from the laticifer ﬂuids of the plants Ervatamia coro-
aria, Funastrum clausum, Carica candamarcencis, Plumeria rubra
nd Cryptostegia grandiﬂora have been previously described [2–5].
eptidases are involved in diverse biological processes such as
ntracellular protein turnover, the ripening of fruits, blood coag-
lation and programmed cell death [6,7]. The role latex peptidases
lay in plant defense has been demonstrated and recently revised
8,9]. Two closely related Apocynaceae species, Calotropis gigantea
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and Calotropis procera,  were also shown to synthesize proteoly-
tic enzymes within the latex [10,11]. The species C. procera has
received special attention because of its use in folk medicine in India
and to a lesser extent in Brazil. Previous reports have conﬁrmed that
the latex of C. procera possesses various pharmacological proper-
ties that may  be used for the treatment of inﬂammatory disorders
such as arthritis, cancer and sepsis [12–15]. The endogenous pro-
teolytic activity of C. procera latex is effectively inhibited by speciﬁc
thiol-inhibitors such as (E-64) and iodoacetic acid (IAA). The pep-
tidase inhibitors leupetin, PMSF, EDTA and EGTA, which inhibit
the proteolytic activity of serine and metallo-peptidases with ele-
vated speciﬁcity, did not reduce the proteolytic activity of the latex
[11]. The major proteolytic activity of C. procera latex is therefore
expected to be associated with cysteine peptidases. The pioneer-
ing studies of Dubey and Jagannadham described the ﬁrst cysteine
peptidase puriﬁed from the latex of C. procera [16]. This enzyme,
named procerain, exhibited a high stability over a broad range of
pH levels and temperatures and blocked N-terminal amino acid
sequence. These authors also suggested that at least four proteoly-
tic enzymes were present within the latex of C. procera.  A second
cysteine peptidase with properties similar to those of procerain was
later puriﬁed from the C. procera latex and named procerain B [17].
In parallel studies, we have investigated the peptidases of C. procera
and their potential activity in different biological process such as
plant defense as well as their pharmacological properties [18,19]. In
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he present study, we report the puriﬁcation of cysteine peptidases
ound in C. procera latex that are distinct from both procerain and
rocerain B. These new peptidases were partially characterized in
erms of enzymatic activity and physicochemical properties. New
nsights into the complex mixture of latex cysteine peptidases in C.
rocera are described.
. Materials and methods
.1. Chemicals
N-Benzoyl-dl-argininyl-p-nitroanilide (BapNA), N-benzoyl-
l-arginine-b-naphthylamide hydrochloride (BANA), transepoxy-
uccinyl-l-leucylamido (4-guanidio)-butane (E-64), azocasein, and
uman (ﬁbrinogen and thrombin) were purchased from Sigma
hemical Co. (St. Louis, MO). Dithiothreitol (DTT), Iodoacetamide,
lycerol, CM-Sepharose Fast-ﬂow, Resource S and molecular
eight markers were purchased from GE HealthCare (Brazil).
thers chemicals were of analytical grade.
.2. Human plasma samples
Human blood certiﬁed for transfusion was donated from the
entre of Hematology and Hemotherapy of the State of Ceará
Ceará, Brazil). Platelet-poor plasma (PPP) was obtained after mix-
ng the samples at a 9:1 (v/v) ratio with 0.11 M tri-sodium citrate
nd centrifuged at 500 × g for 15 min  at 20 ◦C. Tri-sodium citrate
helates calcium from the plasma. Calcium is pivotal in the cascade
f coagulation that follows thrombin activity. Calcium was added
o the reaction medium in all experiments in order to replace the
alcium that was lost.
.3. Latex proteins
The latex of C. procera was obtained and processed as reported
reviously [14]. Brieﬂy, the latex was collected by cutting the termi-
al branches and immediately mixed in distilled water to reach an
qual proportion (latex: water). The samples, maintained at 10 ◦C,
ere centrifuged (10,000 × g; 4 ◦C; 10 min) to eliminate insoluble
hase. The remaining material was dialyzed for 60 h in distilled
ater, at 8 ◦C followed by new centrifugation step as before.
he clean supernatant, comprising the soluble latex proteins was
yophilized. The pool of soluble proteins obtained, known as lati-
ifer proteins (LP), has been extensively characterized in terms of
iological function and pharmacological properties [2,14,15,20].
.4. Separation of peptidases
The passage of LP on a CM-Sepharose fast-ﬂow column
quilibrated in 50 mM acetate-Na buffer pH 5.0 led to three dis-
inct protein fractions. The two later fractions were recovered
ith the increased ionic strength of 200 mM and 300 mM NaCl.
hese protein fractions exhibited proteolytic activity. The detailed
xperimental conditions and the chromatographic proﬁle of this
ractionation process were ﬁrst reported by [14]. In the present
tudy, the protein fraction was washed from the CM-Sepharose
olumn in 200 mM NaCl (LP-PII), dialyzed in distilled water and
yophilized. This was the starting material for the puriﬁcation of the
ewly identiﬁed C. procera peptidases. This starting material was
ubmitted to ion-exchange chromatography on a Resource-S® col-
mn. Runs were automatically monitored by a high-performance
rotein puriﬁer system, which ensured the high reproducibility of
he successive chromatography runs. The initial proteolytic fraction
LP-PII) was dissolved in 20 mM phosphate-buffered saline (PBS)
pH 6.0) and passed through the column. Three partially super-
mposed protein peaks were obtained; all exhibited proteolysis.gical Macromolecules 58 (2013) 211– 219
Cross contamination was eliminated by collecting only the major
peaks of absorbance and re-passing each peak successively in the
column under the same conditions. The puriﬁed proteins were
named CpCP-1, CpCP-2 and CpCP-3 and were examined by differ-
ent chemical, biochemical and biological parameters in an attempt
to determine their properties.
2.5. Electrophoresis
The puriﬁed proteins were separated on 12.5% poly-
acrylamide gels by electrophoresis (plates dimensions:
12 cm × 11 cm × 0.02 cm). Gels were prepared according to
Laemmli [21]. Stacking gel (5% polyacrylamide) was building up in
0.5 M Tris–HCl, pH 6.8 and the main gel in 3 M Tris–HCl, pH 8.8.
Polymerization was  catalyzed by ammonium persulfate (15%) and
TEMED (5 L). The proteins (1 mg/mL) were dissolved in 625 mM
Tris–HCl (pH 6.8) containing 1% SDS and 1% glycerol under native
or reducing (5 mM 2-mercaptoethanol) conditions. Equal amounts
(20 g) of each protein were loaded on the gel. The gel was  run
at 20 mA  and 25 ◦C. The proteins were stained with a colloidal
coomassie brilliant blue (G-250) solution prepared in water/acetic
acid/methanol (5:1:4, v/v/v). The protein proﬁles were observed
after washing the gels with the same solution without the dye.
2.6. Enzymatic assays
The proteolytic activity of the proteins was  determined by col-
orimetric measurements using azocasein, BANA or BApNA as the
substrates [11].
Azocasein was  used as a non-speciﬁc substrate to investigate
total proteolytic activity. The reaction mixtures contained 20 L
of the enzyme (1 mg/mL), which was  added with or without pre-
incubation with 40 L of 3 mM DTT for 10 min, 240 L of buffer
plus 200 L of a 1% solution of azocasein. The reactions were per-
formed at 37 ◦C and stopped after 60 min  by adding 300 L of 20%
trichloroacetic acid (TCA). The tubes were centrifuged (10.000 × g
for 10 min  at 25 ◦C) and the supernatants (400 L) were alkalinized
with 400 L of 2 N NaOH. The developed color was  measured at
an absorbance of 420 nm.  One unit of activity was  deﬁned as the
amount of enzyme capable of increasing absorbance by 420 nm at
0.01 [22]. The proteolytic activities were evaluated using different
pH conditions [50 mM  glycine–HCl, pH 2.5; 50 mM acetate-Na, pH
4.0 and 5.0; 50 mM phosphate-Na, pH 6.0 and 7.0; 50 mM Tris–HCl,
pH 8.0 and 9.0 and 50 mM glycine-Na, pH 10.0] and different tem-
perature conditions [30–90 ◦C] at 15 and 30 min  exposures. Both
set of experiments aimed at determining the best catalytic perfor-
mance of enzymes.
Assays for cysteine peptidase activity were conducted utiliz-
ing BANA as a substrate. The reaction mixtures contained 20 L
of the enzyme (1 mg/mL) pre-incubated with 40 L of 3 mM DTT
and 2 mM EDTA for 10 min  at 37 ◦C, 240 L of buffer and 200 L
of 1 mM BANA. After 30 min, the reaction was stopped by adding
500 L of 2% HCl in ethanol and 500 L of 0.06% 4-(dimethyl-
amino)cinnamaldehyde. After 40 min, the resulting color was
measured by absorbance at 540 nm.  One unit of enzymatic activity
was deﬁned as the amount of enzyme that increases the absorbance
at 540 nm by 0.01 [23].
Assays for serine peptidase activity were performed utilizing
BApNA as a substrate. Aliquots of 20 L of the enzyme (1 mg/mL)
pre-incubated with or without 40 L of 3 mM DTT were incubated
with 280 L (or 320 L) of buffer for 10 min  at 37 ◦C and 500 l
of 1.25 mM BApNA solution were added. After 30 min  at 37 ◦C, the
reaction was stopped by adding 150 L of acetic acid (30%). The
resulting color was  measured by absorbance at 410 nm. One unit
of enzymatic activity was  deﬁned as the amount of enzyme that
increases the absorbance at 410 nm by 0.01 [24].
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The inhibition of proteolytic activity was evaluated by incubat-
ng 20 L aliquots of peptidases (1 mg/mL  in 50 mM phosphate-Na,
H 6.0) for 30 min  at room temperature with 20 L of the following
nhibitors: 0.18 mM E-64, 10 mM  iodoacetate, 5 mM PMSF, 10 mM
DTA or 10 M pepstatine. The residual azocaseinolytic activity
fter each incubation was measured as described above.
Detection of proteolytic activity by zymography was performed
fter the proteins were separated on 12.5% polyacrylamide gels
ith 0.1% gelatin run at 4 ◦C [25]. After electrophoresis, the gels
ere immersed in a 2.5% Triton X-100 renaturing solution and
ently shaken for 30 min  at 25 ◦C to remove the SDS and allow pro-
ein reorganization. The gels were then incubated in 50 mM acetate
uffer (pH 5.0) containing 3 mM DTT for 1 h at 37 ◦C. The incubated
els were stained with a 0.2% coomassie brilliant blue R-250 solu-
ion with 40% methanol and 10% acetic acid. This was followed by
reatment using the same solution without the dye. The enzymatic
ctivity was detected by observing transparent bands in gels.
.7. Mass spectrometry and N-terminal amino acid sequence
nalyses
Mass spectra analyses (ESI Q-TOF) of native latex peptidases
ere performed in a Synapt HDMS mass spectrometer (Waters,
anchester, UK) coupled to a NanoUPLC-ESI system.
The N-terminal amino-acid sequences of puriﬁed peptidases
ere determined by Edman degradation on a Shimadzu PPSQ-23A
utomated protein sequencer [26].
.8. Sequence similarities
The protein BLAST algorithm was used to search available public
equence databases for sequences similar to the unique N-terminal
mino-acid sequence of the puriﬁed peptidases from C. procera
atex. The alignment was built using the non-redundant protein
equence (nr) database from GenBank and the Viridiplantae taxa
s search sets. Following the search, the most signiﬁcant hits (e-
alue > 1e−10) were manually transferred [27].
.9. Circular dichroism (CD)
Circular dichroism (CD) is a valuable technique that provides
 quantitative estimative of secondary structure which can be
ompared with those from X-ray crystallography or NMR  assays.
esides, CD spectra in the different spectral regions are invaluable
or assessing the structural relationships between native, dena-
ured and recombinant proteins, or the structural changes caused
y pH, temperature or the binding of ligands [28].
The native CD spectra of CpCP-1, CpCP-2 and CpCP-3 were
ecorded using a JASCO J-715 spectropolarimeter (Jasco Instru-
ents, Tokyo, Japan). The secondary structures of the proteins were
onitored using the far-ultraviolet CD (far-UV CD) spectra with a
avelength range of 250–190 nm.  The protein concentration was
.3 mg/mL. Samples were measured in a 0.1 cm path length rect-
ngular quartz cuvette at 25 ◦C, and the average of 16 scans was
sed. The near-ultraviolet CD (near-UV CD) spectra were mea-
ured in the range of 350–250 nm.  The protein concentration was
.0 mg/mL. The measurements were taken using the same con-
itions described above. The estimation of secondary structure
as performed using CD spectrum deconvolution with the CDPro
ackage [29]. The possible role of disulﬁde bonds in the structural
tability of each peptidase was investigated by pre-incubating the
roteins with 15 mM DTT before each run. The results of each CD
ere analyzed using the CONTILL software package.gical Macromolecules 58 (2013) 211– 219 213
2.10. Plasma clotting activity
The coagulant activity of each peptidase was measured accord-
ing to the method described by Condrea et al. [30]. To evaluate the
effect of the puriﬁed peptidases (CpCP-1, CpCP-2 and CpCP-3) on
the clotting time of human plasma, the samples (10–80 g) were
reconstituted in 30 L buffer (10 mM Tris–HCl, pH 7.5 with 3 mM
DTT) and incubated with 300 L of plasma for 1 min  at 37 ◦C. The
clot formation was  initiated after the addition of 30 L of 0.25 M
CaCl2. The time taken for the formation of clots after the addition
of 20.8 mM CaCl2 (ﬁnal concentration) was recorded. The effect was
compared with that of the CpLP and CpLP-PII fractions. A control
without any enzyme was  included in this study. The results are
expressed as a mean ± SD of three independent determinations.
2.11. Fibrinogen polymerization assays
Fibrinogen polymerization activity was ﬁrst measured by a spec-
trophotometric assay described by Shivaprasad et al. [31]. Human
ﬁbrinogen (0.5%) in 0.5 mL  of 10 mM Tris–HCl (pH 7.4) was pre-
warmed at 37 ◦C. The formation of ﬁbrin clots was initiated by
adding 5 L of the puriﬁed peptidases (1 mg/mL in tris buffer).
An increase in turbidity, due to ﬁbrin formation, was  recorded by
measuring the absorbance at 540 nm at different time intervals.
The polymerization activity of the puriﬁed peptidases was com-
pared with those of the CpLP and CpLP-PII fractions in the same
conditions.
The activity of the C. procera peptidases on ﬁbrinogen was
also conﬁrmed using the method described by Joo et al. [32]. A
ﬁbrinogen–agarose mixture was  prepared by mixing 3 mL  of 1.2%
agarose (warmed at 50 ◦C) with 3 mL  of 0.4% (w/v) human ﬁbrino-
gen dissolved in 0.1 M Tris–HCl (pH 7.4). The mixture was warmed
at 50 ◦C, and then transferred to glass plates. Solidiﬁcation occurred
at room temperature for 1 h. Wells that were 3 mm in diameter
were made on the plate, and 40 L of puriﬁed peptidases (4 g)
was applied into each well. The samples were incubated at room
temperature for 24 h. The diameter of the turbid ﬁbrin rings formed
around the well indicated the degree of ﬁbrinogen polymerization,
which was  recorded at 3, 6 and 24 h. A buffer-only sample was  used
as a negative control. Samples from the CpLP and CpLP-PII fractions
were assayed in the same conditions as the positive controls.
The time- and dose-dependent kinetics of the ﬁbrinogenolytic
activities of the puriﬁed peptidases were determined using the
method described by Ouyang and Teng [33]. Human ﬁbrinogen
samples (0.2 mL  of 1 mg/mL  solution in Tris buffer) were incubated
with different concentrations of puriﬁed peptidases (0.5–8 g) for
30 min  at 37 ◦C in presence of 3 mM DTT. Sample aliquots of 6 g
were incubated with ﬁbrinogen (200 g), at different time intervals
(0–30 min) at 37 ◦C in a reaction volume of 200 L containing Tris
buffer and 3 mM DTT. The reactions were stopped by adding 20 L
of stop buffer comprising 4% -mercaptoethanol, 1 M urea, and 4%
SDS. The hydrolyzed products were analyzed by 7.5% SDS-PAGE.
2.12. Activated partial thromboplastin time
This coagulation assay (APTT) was performed according to
the manufacturer speciﬁcations. The human plasma (100 L) was
mixed with 40 L of the puriﬁed peptidases (10–80 g) prepared in
buffer (10 mM Tris–HCl, pH 7.5 with 3 mM DTT) and 100 L of acti-
vated partial thromboplastin time (APTT) kit reagent (CLOT, Bios
Diagnóstica) and incubated for 3 min at 37 ◦C. After the incubation
period, 100 L of 25 mM CaCl2 (CLOT, Bios Diagnóstica) was  added
to the mixture, and a coagulometer was used to record the clot-
ting time (DRAKE, QUICK-TIMER model). A negative control was
performed without the addition of an enzyme source (CpLP). As
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Fig. 1. (A) The elution proﬁle of the cysteine peptidases isolated from the latex of Calotropis procera on Resource S® ion-exchange chromatography. The puriﬁed proteins were
individually re-chromatographed under the same experimental conditions: 1 mg/mL  dissolved in PBS pH 6.0; ﬂow rate 1 mL/min. The dotted line shows the salt gradient.
Peaks  are labeled as follows: CpCP-1: (1); CpCP-2: (2); CpCP-3: (3). The chromatographic parameters of each protein are shown in Table 1. The insert shows the initial proﬁle
obtained  when the total proteolytic fraction is chromatographed prior to the separation of the peptidases. The experimental data are described in Section 2. (B) Polyacrylamide
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oaded. The molecular weight markers (MW)  contained the following proteins: pho
lpha-lactalbumin.
ositive controls, samples from the CpLP and CpLP-PII fractions
ere assayed using the same conditions.
.13. Prothrombin time
This assay (PT) was similar to the APTT assay. Initially, 100 L of
uman plasma samples were incubated with 40 L of puriﬁed pep-
idases (10–80 g) prepared in buffer (10 mM Tris–HCl, pH 7.5 with
 mM DTT) for 4 min  at 37 ◦C. After the incubation period, 100 L of
rothrombin time (PT) reagent (CLOT, Bios Diagnóstica) was added
o the mixture. The clotting time was recorded on a coagulometer
DRAKE, QUICK-TIMER model). A negative control was  performed
ithout the addition of enzyme source. Samples from the CpLP and
pLP-PII fractions were assayed using the same conditions and used
s positive controls.
.14. Human plasma clot hydrolyzing activity
The determination of the plasma clot hydrolyzing activity of the
uriﬁed peptidases was performed using the method described by
ajesh et al. [34]. Blood was  collected in tubes containing 2 mg/mL
DTA. Plasma was obtained after centrifugation (500 × g for 15 min
t 20 ◦C). To form a ﬁbrin clot, equal volumes of plasma and 100 mM
aCl2 were mixed. The clot was washed several times with phos-
hate buffered saline and incubated for 1 h at 37 ◦C with 10–80 g
f peptidases in 40 L of tris buffer containing 3 mM DTT. The reac-
ion was terminated by adding the stop buffer described above,
ollowed by boiling (3 min) and centrifugation. A 20 L aliquot of
he supernatant was separated by 7.5% SDS-PAGE.
. Results and discussion
.1. Newly identiﬁed peptidasesThe complete proteolytic activity of C. procera latex is fully
etained on a carboxymethyl-based matrix such as CM-Sepharose
t pH 4.0 or 5.0, as reported here and previously by Dubey and
agannadham [16]. The proteolytic proteins can be separated undernditions (1% 2-mercaptoethanol). Twenty microgram samples of the proteins were
ylase B; bovine serum albumin; ovalbumin; carbonic anhydrase; trypsin inhibitor;
such pH conditions using an increasing salt gradient, which sug-
gests that at least slightly different physico-chemical properties
exist among the different proteins. Procerain and procerain B were
puriﬁed from the different protein peaks that were washed from a
CM-Sepharose column at pH 4.5 [16,35]. In the present study, the
new peptidases were puriﬁed from a protein fraction that is sim-
ilar to that from which procerain was obtained. This preliminary
separation was reported previously [14]. The proteolytic activity is
contained in two distinct protein fractions named CpLP-PII, which
was eluted at a salt concentration of 200 mM,  and CpLP-PIII, which
is obtained within a salt gradient of 300 mM.  Peptidases were puri-
ﬁed from the CpLP-PII fraction. In the ﬁrst attempt, the peptidases
were only partially separated; an extensive overlap region was
observed among their elution proﬁles (see insert of Fig. 1). By pool-
ing the fractions corresponding to the center of each peak and
re-passing them under the same initial conditions, we have suc-
cessfully obtained three distinct puriﬁed proteins. These proteins
were chromatographed under similar conditions, and different
parameters were recorded. As depicted in Fig. 1A, the proteins
exhibited different elution proﬁles along the same increasing salt
gradient. Such differences are described in Table 1. Two pepti-
dases named CpCP-1 and CpCP-2 exhibited similar mass spectra,
suggesting that they may  be the result of slight post-translational
processing. The peptidase CpCP-3 eluted later under the same salt-
gradient conditions and consistently exhibited a molecular mass
distinct from those of other peptidases. CpCP-3 also had a slightly
different electrophoresis pattern when examined under reducing
conditions (Fig. 1B). The proteins exhibited similar proﬁles under
native or reducing conditions suggesting a unique polypeptide
chain as building block. All new peptidases contained identical
N-terminal amino acid sequences (Table 1).
3.2. Enzymatic proﬁlesThe newly identiﬁed peptidases, after ﬁrst being activated by
3 mM DTT, digested azocasein. This activity was slightly reduced
if BANA was used as a substrate (Table 2). No proteolytic activ-
ity was  observed with the substrate BApNA, which is efﬁciently
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Table  1
Comparison of three cysteine peptidases puriﬁed of the latex of C. procera.
Peak Name Elution time (min) Salt concentration (mM)a Yield (%) MS data (ESI-QTOF) N-terminal (Edman degradation)
1 CpCP-1 13.16 21.40 22.3 26,213 FPVPCSVDWREKGALVPIKNQGRCGSCWAF
2  CpCP-2 14.06 24.50 28.7 26,133 FPVPCSVDWREKGALVPIKNQGRCGSCWAF
3  CpCP-3 14.60 26.30 20.
a Salt concentration needed to elute the protein from the column.
Table 2
Proteolytic activity of newlypeptidases from C. procera latex.
Samples Proteolytic activity (AU/g protein)
Azocazein Azocasein + DTT BANA + DTT BApNA + DTT
LP 0.003 ± 0.002 2.75 ± 0.002 1.90 ± 0.001 0.002 ± 0.002
LP-PII 0.002 ± 0.001 2.11 ± 0.001 1.61 ± 0.002 0.001 ± 0.002
CpCP-1 0.02 ± 0.001 2.09 ± 0.002 1.77 ± 0.000 0.002 ± 0.001
CpCP-2 0.006 ± 0.001 2.55 ± 0.003 0.90 ± 0.002 0.003 ± 0.000
CpCP-3 0.000 ± 0.000 2.22 ± 0.002 1.24 ± 0.003 0.007 ± 0.003
Samples were activated by 3 mM DTT. Lack of activity was  also observed when
BApNA was  assayed with enzyme samples that were prepared without DTT.
Table 3
Effect of different peptidase inhibitors on the proteolytic activity of C. procera.
Protein Inhibition of proteolytic activity (%)
E-64 IAA PMSF EDTA Pepstatin A
CpCP-1 97.45 96.80 3.78 3.67 0.70
CpCP-2 99.50 98.24 2.90 0.75 1.25
A
p
C
T
s
s
w
t
p
e
C
n
T
T
T
GCpCP-3 98.91 97.31 2.08 3.26 2.56
ssays were performed similar to those of Table 2. Azocasein was the substrate.
rocessed by serine peptidases. The newly identiﬁed peptidases of
. procera lost enzymatic activity when mixed with E-64 or IAA.
he addition of PMSF, EDTA and Pepstatin did not reduce proteoly-
is (Table 3). These results strongly suggested that these peptidases
hared common catalytic properties with cysteine peptidases. It is
orth noting each of the puriﬁed peptidases exhibited lower pro-
eolytic activity than the mixed CpLP-PII fraction and the total latex
rotein fraction CpLP. This phenomenon was discussed by Singh
t al. [35]. The presence of multiple peptidases in the CpLP and
pLP-PII fractions means that the activity of puriﬁed proteins can-
ot be predictably estimated from their initial sample source. The
able 4
he N-terminal amino acid sequence alignment of C. procera newly peptidases with close
Identiﬁcation Organism Sequence alignmenta
Cysteine peptidase Calotropis procera
(this study)
1FPVPCSVDWREKGALVPIKN
Cysteine peptidase Calotropis procera
(procerain B)
1BLPNSVDWRQKGVVFH16 
Cysteine peptidase Zingiberofﬁcinale 146SIDWREKGAVVAVKNQG
Papain-like Cysteine
peptidase
Sandersoniaaurantiaca 44SVDWREKGAVVPIKDQGG
Putative oryzain beta
chain precursor
Oryzapunctata 139SVDWREKGAVAPVKNQG
cysteine peptidase 1
precursor
Zeamays 142SVDWREKGAVAPVKNQG
a Identical residues at the same position in different sequences aligned are highlighted
able 5
eneral features of cysteine peptidases found in Calotropis procera latex.
Enzyme Reference Mol. weight pH opti
CpCP-1 This study 26,213 (MS) 6.0 
CpCP-2 This study 26,133 (MS) 6.0 
CpCP-3 This study 25,086 (MS) 6.0 
Procerain Dubey and Jagannadham [2003] 28.8 (PAGE) 6.5–8.5
Procerain B Sing et al. [2010] Sing and Dubey [2011] 25.7 (PAGE) 7.0–9.04 25,086 FPVPCSVDWREKGALVPIKNQGRCGSCWAF
mixture of C. procera peptidases is easily observed by zymography
(supplementary material Fig. S1A). The activity of newly peptidases
was stable at a broad range of pH levels, with the maximum activity
observed at pH 6.0. The enzymatic proﬁles of CpCP-2 and CpCP-3
were similar to each other and distinct from the proﬁle of CpCP-1
(supplementary material Fig. S2). The activity of CpCP-1, CpCP-2
and CpCP-3 was  not affected by a heat treatment at 30–50 ◦C in
30 min  intervals (supplementary material Fig. S2). The newly iden-
tiﬁed C. procera latex peptidases are stable proteins that are similar
to procerain and procerain B.
3.3. General structural features of the newly identiﬁed peptidases
of C. procera
The far- and near-UV CD spectra of the newly identiﬁed pep-
tidases suggested that these peptidases share similar folding
patterns (Fig. 2A and B). The secondary structure fractions for
these proteins were as follows: CpCP-1: -helix = 20; -sheet = 26;
-turn = 21; and random coil = 33% (RMSD of 1%); CpCP-2: -
helix = 17; -sheet = 29; -turn = 21 and random coil = 33% RMSD
of 1%); CpCP-3: -helix = 15; -sheet = 30; -turn = 21 and random
coil = 34% (RMSD of 2%). The differences in percentages of secondary
structure estimation, particularly in -helix content, is concern-
ment with higher intensity of spectra shape observed to CpCP-1 for
helix segments (around 222 and 208 nm). The near-UV CD spec-
tra, Fig. 2B, show the aromatic amino acid side-chain contributions.
There are some shoulders in the spectra shape, particularity at 276
and 282 nm that represent the Tyr and Trp contributions. The dou-
ble intensity observed to CpCP-3 can represent the higher content
and/or the exposition of Tyr residues in this enzyme than in CpCP-1
and CpCP-2 [36].
Concerning secondary structure, the newly identiﬁed pepti-
dases resemble procerain; procerain was previously described as 
ly related proteins.
ID (NCBI) % identity e-Value
QGRCGSCWAFH31 – – –
– 8/13 (62%) 2e(−06
RCGSCWAF170 gb|AAW3 4136.1| 21/25 (84%) 2e(−17
CGSCWAF68 gb|AAD28476.1| 22/25 (88%) 3e(−16
QCGSCWAF163 gblAAA-33983 21/25 (84%) 6e(−17
QCGSCWAF166 gb|ACG38442.1| 21/25 (84%) 6e(−17
 in bold.
mum Temperature optimum N-terminal sequence
30–50 FPVPCSVDWREKGALVPIKNQGRCGSCWAF
30–50
30–60
 55–60 Blocked
 40–60 LPNSVDWRQKGVVFH
216 M.V. Ramos et al. / International Journal of Biolo
Fig. 2. The native circular dichroism spectra of the cysteine peptidases isolated from
the Calotropis procera latex. The far-UV spectrum (A) and near-UV spectrum (B) sug-
gest that the proteins contain similar secondary and tertiary structures. The bottom
panel (C) shows that the correct folded structure of the peptidases is lost in the
presence of a reducing agent (15 mM DTT). This result suggests the stability of the
proteins is dependent on disulﬁde bonds formation.gical Macromolecules 58 (2013) 211– 219
plus  protein [16]. No similar data are available for procerain B. The
newly identiﬁed C. procera peptidases completely lost their ordered
structure when treated with 15 mM DTT prior to CD analysis
(Fig. 2C). These proteins exhibited increased proteolytic activities
in the presence of 3 mM DTT (Table 2). DTT concentrations above
10 mM can lead to reduced disulﬁde bonds in proteins. It is assumed
that the folded peptidases reported here are stabilized by disul-
ﬁde bonds, however at 3 mM DTT catalytic cysteine residues can be
reduced and therefore increase their catalytic activities. Other cys-
teine peptidases exhibit internal disulﬁde bonds [37]. Procerain and
procerain B were estimated to possess 7 and 9 cysteine residues,
respectively; these cysteine residues may  be involved in 3 and 4
disulﬁde bonds in procerain and procerain B, respectively [16,35].
The unique N-terminal amino acid sequences of the new pep-
tidases of C. procera latex were aligned. A protein BLAST identiﬁed
strong sequence identities to other plant cysteine peptidases,
including procerain B (Table 4). This result conﬁrmed the new pep-
tidases described here.
3.4. CpCP-1, CpCP-2 and CpCP-3 are distinct from procerain and
procerain B
Table 5 summarizes a set of data concerning the newly iden-
tiﬁed and previously described cysteine peptidases of C. procera
latex. The newly identiﬁed peptidases were puriﬁed from the frac-
tion that is expected to contain procerain. N-terminal amino acid
sequencing is blocked in procerain; however, automatic sequenc-
ing applied here allowed the ﬁrst forty amino acid residues of the
newly identiﬁed peptidases to be determined. The newly identi-
ﬁed peptidases differ from procerain B in N-terminal amino acid
sequence and molecular mass (CpP-1 and CpP-2), although differ-
ent methods with varying sensitivity were used to estimate the
molecular mass of these proteins.
Limited information is presently available concerning the
genomic distribution of cysteine peptidases in plants. A com-
parative analysis was performed using genes coding for cysteine
peptidases in the MEROPS database (merops.sanger.as.uk) for the
two sequenced dicotyledonous genomes of Arabidopsis thaliana and
Populus trichocarpa. This analysis suggested a multigenic origin of
cysteine peptidases [38]. Thirty-eight and forty-four cysteine pro-
teinase genes were described for A. thaliana and P. trichocarpa,
respectively.
At least four cysteine peptidases were isolated in the latex
of Carica papaya.  These enzymes had closely related structural
and enzymatic characteristics and were considered isoforms [39].
Chymopapain has a set of isoforms with a peculiar characteris-
tic due to a free cysteine residue at position 117 that is neither
involved in disulﬁde-bonds nor part of the catalytic site [40].
Important differences are found among the multiple isoforms of
these enzymes in C. papaya latex; the molecular mass, number
of disulﬁde-bonds stabilizing the structure and post-translational
processing can vary. The literature and our present study sug-
gest that the situation may  be similar in the latex of C. procera.
The new peptidases reported here are most likely isoforms of a
single protein and are segregated by minor differences in amino
acid sequences due to post-translational processing. To correctly
describe each isoform, the number of cysteine residues and disul-
ﬁde bonds, the glycosylation status and the primary sequence
length may  need to be identiﬁed. These newly identiﬁed pepti-
dases can be considered distinct from procerain and procerain B and
these two  later are also different proteins each other. The results
previously published and those presented here support the pre-
diction that the cysteine peptidases of C. procera latex belong to a
multigenic family. Only further genomic analysis can conﬁrm this
hypothesis.
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Fig. 3. Plasma clotting activity and ﬁbrinogenolytic activity as analyzed by spectrophotometric assays. (A) The dose-response of latex proteins (CpLP), its sub-fraction obtained
after  passage on CM-Sepharose fast-ﬂow (CpLP – PII), and the puriﬁed peptidases obtained from CpLP – PII (CpCP-1, CpCP-2 and CpCP-3) after Resource S® ion-exchange
chromatography on clotting formation. Human plasma (300 l) was incubated for 1 min  at 37 ◦C with the latex fractions and the puriﬁed peptidases (5–80 g) that were
prepared in Tris buffer. A CaCl2 solution (30 l, 0.25 M)  was added to the pre-incubated mixture. The time elapsed for the formation of clot was  recorded. The values represent
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bhe  mean ± SEM (n = 3). (B) Spectrophotometric analysis of ﬁbrin clot formation and
dded  to 0.5 mL of a 0.5% ﬁbrinogen solution. The appearance of turbidity due to the
lot  was  recorded by measuring the absorbance at 540 nm.  The data presented repr
.5. Plasma clotting activity
The effects of latex proteins on human plasma clotting have been
eported recently [18]. CpLP showed concentration-dependent
roteolytic activity and time-reducing plasma clotting activity. The
. procera peptidases were assumed to be directly involved in this
ctivity [18]. Because we have now successfully puriﬁed the pro-
eolytic fraction of the latex, a set of assays was performed to
onﬁrm the results of previous studies that used the whole pro-
ein fraction of the latex (CpLP). As seen in Fig. 3A, each puriﬁed
eptidase had similar kinetics to the CpLP or CpLP-PII fractions and
educing clotting-time in a concentration-dependent manner. All
eptidases exhibited ﬁbrinolytic activity. They were more effective
han both the CpLP and CpLP-PII fractions (Fig. 3B). A time-course
garose-plate diffusion assay conﬁrmed the proteolytic processing
f ﬁbrinogen by the latex peptidases (Fig. 4). In both assays, CpCP-
 exhibited faster proteolysis than did CpCP-2 and CpCP-3. The
ribrinogenolytic activity of all three peptidases was considered
o be thrombin-like; the progressive proteolysis of ﬁbrinogen sub-
nits (A,  B and ) was observed in a time- and dose-dependent
anner (supplementary material Fig. S3). The newly identiﬁed C.
rocera peptidases were also capable of partially digesting plasma
lots (supplementary material Fig. S4).
In our previous study, the fractions CpLP and CpLP-PII were
hown to accelerate the coagulation cascade by the intrinsic path-
ay, reducing clotting-time by 50% [18]. No effect was  observed in
he PT assay, suggesting that the clotting activity was  dependent on
he initial steps of the coagulation cascade involving XII, XI and IX
ig. 4. A ﬁbrinogen-agarose plate assay used to determine the thrombin-like activity of the
repared in 40 l of Tris buffer and poured into wells on a ﬁbrinogen–agarose plate. The a
ccurred. Measurements were taken after 3, 6, and 24 h of incubation at 25 ◦C. The CpLP a
uffer alone was used as a negative control.drolysis by the latex fractions and the puriﬁed peptidases. The samples (5 l) were
ation of ﬁbrin clot and the disappearance of turbidity due to the hydrolysis of ﬁbrin
s mean ± SD of four individual experiments.
factors. Similar results were obtained in the present study (Fig. 5A
and 5B). CpCP-1 performed similarly to the CpLP and CpLP-PII frac-
tions in the PT assay; CpCP-2 and CpCP-3 consistently reduced
clotting-time in both APTT and PT assays (Fig. 5B). Such discrepan-
cies may  be due to the total concentration of each enzyme within
the mix  of the CpLP fraction when ﬁrst evaluated.
3.6. Biotechnological applications of laticifer peptidases
Peptidases have broad and established applications in industrial
markets such as cleaners and detergents. Procerain B demonstrated
detergent activity when used to clean a blood stain on cotton [35].
Singh and Dubay [17] proposed that procerain B may  help in the
digestion of food proteins. We  tested the possible toxicity of the
CpLP fraction in rats, which were given samples orally for 35 days.
The animals fed CpLP samples were found to be completely free
of detectable toxicology and exhibited growth similar to that of
the control animals; the animals appeared to greatly appreciate
consuming the CpLP; there was  no observed feeding inhibition in
animals given CpLP samples (personal observations). We  hypoth-
esized that the peptidases present in the CpLP fraction supported
food digestion. The biotechnological application of latex peptidases
in the control of helminthic parasitosis in goats has also been pro-
posed [41].An important potential use of latex peptidases is in milk clot-
ting activities. Plant coagulants are of great interest to this market
because the use of animal rennet is limited for various reasons,
religious issues being the most prevalent [42].
 puriﬁed peptidases (CpCP-1, CpC-2 and CpC-3). The samples (40 g of protein) were
ppearance of a turbid ring around the well indicates that ﬁbrinogen polymerization
nd CpLP-PII fractions were used as positive control using the same conditions. Tris
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Fig. 5. The effect of different concentrations of the puriﬁed peptidases CpCP-1 (), CpCP-2 () and CpCP-3 () on activated partial thromboplastin time (APTT – A) and
pro-thrombin time (PT – B). (A) Human plasma (100 l) and APTT (100 l, CLOT – Bios Diagnóstica) were incubated with 40 l of the latex protein fractions in pH 7.4 Tris
buffer  in the presence of 3 mM DTT for 3 min  at 37 ◦C. CaCl2 (100 l, 0.25 M,  CLOT – Bios Diagnóstica) was  added, and the time taken for the formation of clot was recorded.
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[B)  Human plasma (100 l) was incubated with 40 l of the latex protein fractions
ios  Diagnóstica) was added to the sample and the time taken for the formation of
xperiments. Samples from the CpLP () and CpLPPII (©) fractions were used as po
Pharmacological potentials of peptidases have also been dis-
ussed. Healing activity has been proposed as the case of peptidases
f Carica candamarcensis latex that increases ﬁbroblast proliferation
43]. Other studies involving cysteine peptidases obtained of dif-
erent latex ﬂuids have underscoring their thrombin-like activity
32,34,44]. Shivaprasad et al. [31] which reported the thrombin-
ike activity of Pergularain e I, puriﬁed of latex of Pergularia extensa
iscussed aspects of the putative mechanism of action of these
eptidases on the cascade of coagulation. Pergularain e I, simi-
ar to the C. procera peptidases, digests most efﬁciently A and
 subunits of ﬁbrinogen. Therefore, latex peptidases exhibiting
hrombin-like activity are potential tools for activating coagulation
ascade under adverse physiological conditions such as bleeding;
emorrhagic dengue or hemophilia. However, strategies for per-
orming such uses are still to be investigated. Even, the intervention
f exogenous peptidases in the cascade of coagulation deserves
ore detailed studies. For instance, the proteolytic fraction of
. procera reduced time of coagulation of healthy animals while
xtended time of coagulation of animals submitted to sepsis [18].
. Conclusion
A mixture of closely related cysteine peptidases is found in the
atex of C. procera. The enzymatic activity and molecular features
f these proteins have been partially characterized by biochemical
nd spectroscopic studies. Although the proteins exhibit certain
istinguishing characteristics, these peptidases share important
imilarities; therefore, it is proposed that they may  be products of
 multigenic family or correspond to different post-translationally
rocessed forms of the same protein. This hypothesis will be
alidated by the molecular analysis of the genes involved. This
trategy is currently being explored. The role these enzymes
lay in the latex remains to be studied. Souza et al. [19] sug-
ested that the proteolytic activity of the C. procera latex could
e involved in plant defense against phytopathogens. The newly
dentiﬁed enzymes are also potential tools for biotechnological
pplications.
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[ 7.4 Tris buffer in the presence of 3 mM DTT for 3 min  at 37 ◦C. PT (100 l, CLOT -
as recorded. The values represent the mean ± SD of the measurements from three
 controls.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.ijbiomac.
2013.04.001.
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